Anisindione Market Analysis - Forecast(2022 - 2027)

Report Code: CMR 0335 Report Format: PDF + Excel

Anisindione Market Overview

Anisindione Market size is forecast to reach US$ 155 million by 2026, after growing at a CAGR 5.08% during 2021-2026. Anisindione is a man-made anticoagulant that prevents the formation of active procoagulation factors IIX, IX, VII, and II, as well as the anticoagulant proteins S and proteins C, in the liver by slowing down the gamma carboxylation process of vitamin K of precursor proteins. Globally, the rising demand for anisindione as an anticoagulant, in the antithrombotic drugs to aid in reducing thrombus formation is anticipated to raise the growth for the market. Additionally, increasing government investments in the medical and pharmaceutical sectors is estimated to boost the market growth. Moreover, the increasing usage of anisindione in protein hydrolysis and to reduce the frequency of existing thrombi extension and help to avoid thromboembolic complications is projected to boost the anisindione industry in the projected time frame.

Impact of Covid-19

Due to the COVID-19 pandemic the pharmaceutical production plants were shut down in the year 2020 which affected the growth of the anisindione market. Due to the import-export supply chain disruption, the availability of raw materials declined which further affected the market growth. Furthermore, considering the new normal condition and reopening of several industries in various regions, it is estimated that the market for anisindione will return to normal conditions in the forecast period (2021-2026).

Report Coverage

The: “Anisindione Market Report – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the anisindione market.

By Product Type: Oral Drugs and Injectable Drugs.
By Application: Protein Hydrolysis, Anticoagulant, Atrial fibrillation with Embolization, Pulmonary Embolism, Coronary Occlusion, and Others.
By Geography: North America (USA, Canada, and Mexico), Europe (UK, Germany, Italy, France, Spain, Netherlands, Russia, Belgium, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia and New Zealand, Taiwan, Indonesia, Malaysia, and Rest of Asia Pacific),South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and RoW (Middle East and Africa). 

Key Takeaways

  • Europe region dominated the anisindione market due to the huge government investments made in the pharmaceutical industries in emerging economies such as UK, Germany, France, and Italy. 
  • Globally, the increasing demand for protein hydrolysis enzymes, owing to its alluring benefits is estimated to drive the growth of the anisindione market in the projected period.
  • The rising usage of oral and injectable drugs for curing and preventing arterial and venous thrombosis will drive up the demand for anisindione and raise the market growth over the forecast period.


Figure: Europe Anisindione Market Revenue, 2020-2026 (US$ Million)

Europe Anisindione Market Revenue, 2020-2026

For More Details on This Report - Request for Sample

Anisindione Market Segment Analysis - By Product Type

Oral Drugs held the largest share in the anisindione market in 2020. During the course of heparin, oral drugs are used to prevent the progression or recurrence of acute deep vein thrombosis or pulmonary embolism. Also, oral drugs are good at preventing venous thromboembolism in individuals having orthopaedic or gynecological surgery, as well as systemic embolization in patients who have had a heart attack, have artificial heart valves, or have chronic atrial fibrillation. Furthermore, the increasing usage of oral anticoagulants drugs is effective in the prevention and treatment of a wide range of thromboembolic diseases. Thus, rising usage of oral drugs would further drive the growth of the market over the forecast period.

Anisindione Market Segment Analysis - By Application

Protein Hydrolysis held the largest share in the anisindione market in 2020and is projected to grow at a CAGR of 6.54% during 2021-2026. Major growth factors such as the modification and developments of features in food proteins, as well as the reduction in feed costs for protein hydrolysis enzymes, are expected to fuel demand for these enzymes. Other reasons, such as the increased use of protease enzymes in the reduction of phosphorus pollution and nitrogen content, are expected to contribute to the market's expansion. However, the market's growth is likely to be hampered by reasons such as the restricted number of applications of these enzymes in food applications and the increased use of chemicals as a substitute. Therefore, the increasing usage of anisindione in protein hydrolysis is estimated to drive the growth of the market.

Anisindione Market Segment Analysis - By Geography

The Europe region held the largest share of more than 37% in the anisindione market in 2020. Globally, the region's growth in the market is mainly due to the rising investments in the healthcare and pharmaceutical sector. Rising investments for pharmaceutical industry in emerging economies such as UK, Germany, France, and Italy are increasingly driving the growth of the anisindione market. According to the European Federation of Pharmaceutical Industries and Association, in 2019, Europe accounted for 22.9% of world pharmaceutical sales. According to IQVIA (MIDAS May 2020), 18.4% of sales of new medicines launched during the period 2014-2019 were from the European market. Thus, with the rising growth of the pharmaceutical industry, the anisindione market is anticipated to increase in the forecast period.

Anisindione Market Drivers

Rising Growth of Arterial and Venous Thrombosis Among Individuals

Thrombosis occurs when blood clots block the blood vessels. Veins transport blood back to the heart from the rest of the body. Increasing disease or injury to the leg veins, fracture, and consumption of medicines that increase the risk of clotting (such as certain birth control medicines) result in venous thrombosis. In recent years, rising venous thrombosis among people have raised the demand for anisindione. For instance, according to the Data & Statics of Centers for Disease Control and Prevention as of February 7, 2020, the exact number of people afflicted by DVT/PE(venous thrombosis) in the United States, is up to 900,000 people (1 to 2 per 1,000) impacted each year. Similarly, when a blood clot plugs an artery, it is known as arterial thrombosis. Arteries transport oxygen-rich blood from the heart to the rest of the body. With the rising arterial and venous thrombosis among individuals it can be estimated that the demand for anisindione would increase which would further drive the market growth.

Anisindione Market Challenges

Rising Side Effects will Hamper the Market Growth

The main challenges faced by the anisindione market are the rising side effects. Nausea, diarrhoea, pyrexia, dermatitis or exfoliative dermatitis, urticaria, alopecia, and sore mouth or mouth ulcers have all been documented as side effects of coumarin or indanedione anticoagulant medication. Furthermore, vomiting, abdominal cramps, anorexia, priapism, erythema, and necrosis of the skin and other tissues, appearing as purple toes and cutaneous gangrene, is estimated to hinder the adoption of anisindione over the forecast period. However, changing from one chemical type of oral anticoagulant to another can help you avoid unpleasant side effects like rash or diarrhoea. The only side effect reliably linked to anisindione therapy is dermatitis. Thus, due to the rising side effects the market growth for anisindione is estimated to face challenges in the upcoming years.

Anisindione Market Landscape

Technology launches, acquisitions, and R&D activities are key strategies adopted by players in the anisindione market. Major players in the anisindione market are:

  • Aimpow
  • Toronto Research Chemicals Inc.
  • Santacruz Biotechnology
  • Schering Plough Corp
  • Bayer Schering Pharma and among others.

Relevant Reports

Sodium Acetate Market - Forecast(2021 - 2026)
Report Code: CMR 0840

Diethylenetriamine Market - Forecast(2021 - 2026)
Report Code: CMR 0456

For more Chemicals and Materials Market reports, please click here

1. Anisindione Market - Market Overview
    1.1 Definitions and Scope
2. Anisindione Market - Executive Summary
    2.1 Key Trends by Type
    2.2 Key Trends by Application
    2.3 Key Trends by Geography
3. Anisindione Market - Comparative analysis
    3.1 Market Share Analysis- Major Companies
    3.2 Product Benchmarking- Major Companies
    3.3 Top 5 Financials Analysis
    3.4 Patent Analysis- Major Companies
    3.5 Pricing Analysis (ASPs will be provided)
4. Anisindione Market - Startup companies Scenario Premium Premium 
    4.1 Major startup company analysis:
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Product portfolio
        4.1.4 Venture Capital and Funding Scenario
5. Anisindione Market – Industry Market Entry Scenario Premium Premium 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Successful Venture Profiles
    5.4 Customer Analysis - Major Companies
6. Anisindione Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Buyers
        6.3.3 Threat of New Entrants
        6.3.4 Competitive Rivalry
        6.3.5 Threat of Substitutes
7. Anisindione Market -Strategic analysis
    7.1 Value/Supply Chain Analysis
    7.2 Opportunity Analysis
    7.3 Product/Market Life Cycle
    7.4 Distributor Analysis – Major Companies
8. Anisindione Market – By Type (Market Size -US$ Million)
    8.1 Oral Drugs
    8.2 Injectable Drugs
9. Anisindione Market – By Application (Market Size -US$ Million)
    9.1 Anticoagulant
    9.2 Protein Hydrolysis
    9.3 Atrial Fibrillation with Embolization
    9.4 Pulmonary Embolism
    9.5 Coronary Occlusion
    9.6 Others
10. Anisindione Market - By Geography (Market Size -US$ Million)
    10.1 North America
        10.1.1 USA
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 UK
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Netherlands
        10.2.6 Spain
        10.2.7 Russia
        10.2.8 Belgium
        10.2.9 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 India
        10.3.4 South Korea
        10.3.5 Australia and New Zealand
        10.3.6 Indonesia
        10.3.7 Taiwan
        10.3.8 Malaysia
        10.3.9 Rest of Asia Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Colombia
        10.4.4 Chile
        10.4.5 Rest of South America
    10.5 ROW
        10.5.1 Middle East
            10.5.1.1 Saudi Arabia
            10.5.1.2 UAE
            10.5.1.3 Israel
            10.5.1.4 Rest of Middle East
        10.5.2 Africa
            10.5.2.1 South Africa
            10.5.2.2 Nigeria
            10.5.2.3 Rest of South Africa
11. Anisindione Market - Entropy
    11.1 New Product Launches
    11.2 M&A’s, Collaborations, JVs and Partnerships
12. Anisindione Market- Industry/Segment Competition Landscape Premium
    12.1 Company Benchmarking Matrix – Major Companies
    12.2 Market Share at Global Level- Major companies
    12.3 Market Share by Key Region- Major companies
    12.4 Market Share by Key Country- Major companies
    12.5 Market Share by Key Application - Major companies
    12.6 Market Share by Key Product Type/Product category- Major companies
13. Anisindione Market - Key Company List by Country Premium Premium 
14. Anisindione Market Company Analysis- Business Overview, Product Portfolio, Financials, and Developments
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
List of Tables

Table 1: Anisindione Market Overview 2021-2026
Table 2: Anisindione Market Leader Analysis 2018-2019 (US$)
Table 3: Anisindione Market Product Analysis 2018-2019 (US$)
Table 4: Anisindione Market End User Analysis 2018-2019 (US$)
Table 5: Anisindione Market Patent Analysis 2013-2018* (US$)
Table 6: Anisindione Market Financial Analysis 2018-2019 (US$)
Table 7: Anisindione Market Driver Analysis 2018-2019 (US$)
Table 8: Anisindione Market Challenges Analysis 2018-2019 (US$)
Table 9: Anisindione Market Constraint Analysis 2018-2019 (US$)
Table 10: Anisindione Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Anisindione Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Anisindione Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Anisindione Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Anisindione Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Anisindione Market Value Chain Analysis 2018-2019 (US$)
Table 16: Anisindione Market Pricing Analysis 2021-2026 (US$)
Table 17: Anisindione Market Opportunities Analysis 2021-2026 (US$)
Table 18: Anisindione Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Anisindione Market Supplier Analysis 2018-2019 (US$)
Table 20: Anisindione Market Distributor Analysis 2018-2019 (US$)
Table 21: Anisindione Market Trend Analysis 2018-2019 (US$)
Table 22: Anisindione Market Size 2018 (US$)
Table 23: Anisindione Market Forecast Analysis 2021-2026 (US$)
Table 24: Anisindione Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 26: Anisindione Market By Application, Revenue & Volume,By Anticoagulant, 2021-2026 ($)
Table 27: Anisindione Market By Application, Revenue & Volume,By Protein Hydrolysis, 2021-2026 ($)
Table 28: North America Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 29: South america Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 30: Europe Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 31: APAC Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 32: Middle East & Africa Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 33: Russia Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 34: Israel Anisindione Market , Revenue & Volume,By Application, 2021-2026 ($)
Table 35: Top Companies 2018 (US$)Anisindione Market , Revenue & Volume
Table 36: Product Launch 2018-2019Anisindione Market , Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019Anisindione Market , Revenue & Volume


List of Figures

Figure 1: Overview of Anisindione Market 2021-2026
Figure 2: Market Share Analysis for Anisindione Market 2018 (US$)
Figure 3: Product Comparison in Anisindione Market 2018-2019 (US$)
Figure 4: End User Profile for Anisindione Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Anisindione Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Anisindione Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Anisindione Market 2018-2019
Figure 8: Ecosystem Analysis in Anisindione Market 2018
Figure 9: Average Selling Price in Anisindione Market 2021-2026
Figure 10: Top Opportunites in Anisindione Market 2018-2019
Figure 11: Market Life Cycle Analysis in Anisindione Market
Figure 12: GlobalBy ApplicationAnisindione Market Revenue, 2021-2026 ($)
Figure 13: Global Anisindione Market - By Geography
Figure 14: Global Anisindione Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 15: Global Anisindione Market CAGR, By Geography, 2021-2026 (%)
Figure 16: North America Anisindione Market Value & Volume, 2021-2026 ($)
Figure 17: US Anisindione Market Value & Volume, 2021-2026 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Anisindione Market Value & Volume, 2021-2026 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Anisindione Market Value & Volume, 2021-2026 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Anisindione Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil Anisindione Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Anisindione Market Value & Volume, 2021-2026 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Anisindione Market Value & Volume, 2021-2026 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Anisindione Market Value & Volume, 2021-2026 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Anisindione Market Value & Volume, 2021-2026 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Anisindione Market Value & Volume, 2021-2026 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Anisindione Market Value & Volume, 2021-2026 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Anisindione Market Value & Volume, 2021-2026 ($)
Figure 59: U.K Anisindione Market Value & Volume, 2021-2026 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Anisindione Market Value & Volume, 2021-2026 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Anisindione Market Value & Volume, 2021-2026 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Anisindione Market Value & Volume, 2021-2026 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Anisindione Market Value & Volume, 2021-2026 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Anisindione Market Value & Volume, 2021-2026 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Anisindione Market Value & Volume, 2021-2026 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Anisindione Market Value & Volume, 2021-2026 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Anisindione Market Value & Volume, 2021-2026 ($)
Figure 92: China Anisindione Market Value & Volume, 2021-2026
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Anisindione Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Anisindione Market Value & Volume, 2021-2026 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Anisindione Market Value & Volume, 2021-2026 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Anisindione Market Value & Volume, 2021-2026 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Anisindione Market Value & Volume, 2021-2026 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Anisindione Market Value & Volume, 2021-2026 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Anisindione Market Value & Volume, 2021-2026 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Anisindione Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 121: Russia Anisindione Market Value & Volume, 2021-2026 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Anisindione Market Value & Volume, 2021-2026 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Anisindione Market 
Figure 130: Developments, 2018-2019*Anisindione Market 
Figure 131: Company 1 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Anisindione Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Anisindione Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Anisindione Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Anisindione Market Net Sales Share, By Geography, 2018 (%)